Astrazeneca Pharma India Ltd vs Natural Capsules Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 15, 2026

Key Highlights

The Latest Trading Price of Astrazeneca Pharma India Ltd is ₹ 8243 as of 12 Jun 15:30 . The P/E Ratio of Astrazeneca Pharma India Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Natural Capsules Ltd changed from 9.7 on March 2021 to 307 on March 2025 . This represents a CAGR of 99.56% over 5 years The Market Cap of Astrazeneca Pharma India Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Natural Capsules Ltd changed from ₹ 67.03 crore on March 2021 to ₹ 190.48 crore on March 2025 . This represents a CAGR of 23.23% over 5 years The revenue of Astrazeneca Pharma India Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Natural Capsules Ltd for the Mar '26 is ₹ 59.22 crore as compare to the Dec '25 revenue of ₹ 38.19 crore. This represent the growth of 55.07% The ebitda of Astrazeneca Pharma India Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Natural Capsules Ltd for the Mar '26 is ₹ 2.09 crore as compare to the Dec '25 ebitda of ₹ -1.88 crore. This represent the decline of -211% The net profit of Astrazeneca Pharma India Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The net profit of Natural Capsules Ltd changed from ₹ 0.6 crore to ₹ -4.98 crore over 8 quarters. This represents a CAGR of NaN% The Dividend Payout of Astrazeneca Pharma India Ltd changed from 5.36 % on March 2021 to 69.12 % on March 2025 . This represents a CAGR of 66.76% over 5 yearsThe Dividend Payout of Natural Capsules Ltd changed from 8.96 % on March 2021 to 0 % on March 2025 . This represents a CAGR of -100.00% over 5 years .

About Astrazeneca Pharma India Ltd

AstraZeneca Pharma India Limited (APIL) was incorporated on July 11, 1979.
The Company is engaged in the business of manufacture, distribution and marketing of pharmaceutical products and co-ordinates clinical trial services with an overseas group company.
The major therapy areas where the company operates are Onocology, Alimentary & Metabolism, Cardio Vascular, Renal, Diabetes, Respiratory and Oncology. AstraZeneca Pharma India, formerly known as Astra-IDL (AIL), was an erstwhile joint venture of Astra Zeneca, UK and Hinduja controlled IDL. Astra Pharmaceuticals AB, Sweden acquired all of the 1287500 equity shares in the Company of IDL, representing 25.75% of the Company's issued and paid up equity share capital.
Consequently, the Company became a subsidiary of Astra, which is a direct wholly owned subsidiary of Astra AB, Sweden (now known as AstraZeneca Pharmaceuticals AB Sweden) and an indirect wholly owned subsidiary of AstraZeneca Plc, the Group parent Company.

About Natural Capsules Ltd

Natural Capsules Limited was incorporated as Public Limited Company established in 1993 at Bangalore.
The Company is one of the leading manufacturers of hard capsule shells in India.
The Company introduced vegetarian capsules to Indian market and is the second-largest manufacturer of gelatin capsules in the country. Company expanded its operations to Puducherry in 2003, further solidifying its position as a trusted brand in the industry.
By venturing into API manufacturing under its subsidiary, Natural Biogenex Private Limited, Company presently operates two distinct business verticals-Capsules and APIs.
The company is a well-equipped modern manufacturing plant to manufacture Hard Gelatin Capsule shells, Hard Cellulose Capsule shells and Pharmaceutical Dosage Forms in Capsule Dosage Form.

FAQs for the comparison of Astrazeneca Pharma India Ltd and Natural Capsules Ltd

Which company has a larger market capitalization, Astrazeneca Pharma India Ltd or Natural Capsules Ltd?

Market cap of Astrazeneca Pharma India Ltd is 20,609 Cr while Market cap of Natural Capsules Ltd is 160 Cr

What are the key factors driving the stock performance of Astrazeneca Pharma India Ltd and Natural Capsules Ltd?

The stock performance of Astrazeneca Pharma India Ltd and Natural Capsules Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Astrazeneca Pharma India Ltd and Natural Capsules Ltd?

As of June 15, 2026, the Astrazeneca Pharma India Ltd stock price is INR ₹8243.9. On the other hand, Natural Capsules Ltd stock price is INR ₹154.2.

How do dividend payouts of Astrazeneca Pharma India Ltd and Natural Capsules Ltd compare?

To compare the dividend payouts of Astrazeneca Pharma India Ltd and Natural Capsules Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.